When conventional treatments are not enough, advanced therapies offer new possibilities. For patients dealing with severe inflammatory bowel conditions, Dr. Harshad Joshi in Mumbai may consider biologic treatments like infliximab as part of a carefully planned approach.
Infliximab works by targeting specific pathways in the immune system that cause inflammation in conditions like Crohn’s disease and ulcerative colitis. It is typically recommended for moderate to severe cases where symptoms persist despite standard treatment. This therapy has helped many patients achieve better control over flare-ups and maintain longer periods of remission.
The decision to start infliximab is always based on detailed evaluation, including disease severity, response to previous treatments, and overall health. Regular monitoring ensures safety and effectiveness. With the right supervision, patients often experience improved quality of life and reduced dependency on multiple medications.
If your condition is not responding to usual treatments, connect with Dr. Harshad Joshi in Mumbai to explore advanced therapy options tailored to your needs.
